Active Ingredient History
Phenylephrine is a medication primarily used as a decongestant, to dilate the pupil, to increase blood pressure, and to relieve hemorrhoids. It was long maintained that when taken orally as a decongestant, it relieves nasal congestion due to colds and hay fever. Phenylephrine can be taken by mouth, as a nasal spray, given by injection into a vein or muscle, or applied to the skin. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acute Kidney Injury (Phase 4)
Acute Lung Injury (Phase 2)
Acute Pain (Phase 1/Phase 2)
Aged (Phase 4)
Allergy and Immunology (Phase 3)
Anesthesia (Phase 4)
Anesthesia, Epidural (Phase 4)
Anesthesia, General (Phase 4)
Anesthesia, Intravenous (Phase 4)
Anesthesia, Obstetrical (Phase 2)
Anesthesia, Spinal (Phase 4)
Arrhythmias, Cardiac (Phase 4)
Autonomic Nervous System Diseases (Phase 1)
Blood Loss, Surgical (Phase 1)
Blood Pressure (Phase 4)
Brain Neoplasms (Phase 4)
Bronchiolitis (Phase 2)
Cardiac Output (Phase 4)
Cardiac Output, Low (Phase 4)
Cardiovascular Diseases (Phase 1)
Cataract (Phase 4)
Cesarean Section (Phase 4)
Cognition Disorders (Phase 3)
Cold Temperature (Phase 3)
Common Cold (Phase 4)
Corneal Endothelial Cell Loss (Phase 3)
Corneal Transplantation (Phase 4)
Cough (Phase 4)
Diabetes Mellitus (Phase 4)
Dopamine beta-Hydroxylase (Phase 1)
Echocardiography (Phase 4)
Endotoxemia (Phase 4)
Essential Hypertension (Phase 1)
Extracorporeal Membrane Oxygenation (Phase 4)
Eye Diseases (Phase 3)
Fecal Incontinence (Phase 3)
Fluid Therapy (Phase 3)
General Surgery (Phase 4)
Healthy Volunteers (Phase 4)
Heart Disease Risk Factors (Phase 1)
Heart Rate (Phase 1/Phase 2)
Hemodynamics (Phase 4)
Hemorrhoids (Phase 3)
HIV Infections (Phase 4)
Horner Syndrome (Phase 4)
Human Experimentation (Phase 3)
Hypertension (Phase 1)
Hypotension (Phase 4)
Hypotension, Orthostatic (Phase 1)
Hypoxia (Phase 1)
Infant, Premature (Phase 4)
Inflammation (Phase 3)
Influenza A virus (Phase 3)
Influenza, Human (Phase 4)
Intraocular Pressure (Phase 4)
Ischemic Stroke (Phase 3)
Kidney Diseases (Phase 4)
Lens Diseases (Phase 3)
Lung (Phase 4)
Macular Edema (Phase 3)
Mitral Valve Insufficiency (Phase 1/Phase 2)
Mouth Mucosa (Phase 1/Phase 2)
Mucositis (Phase 1)
Mydriasis (Phase 4)
Nasal Obstruction (Phase 3)
Neoplasms (Phase 1/Phase 2)
Obesity (Early Phase 1)
Ocular Physiological Phenomena (Phase 2)
Organ Transplantation (Phase 2)
Orthostatic Intolerance (Phase 1)
Ovarian Cysts (Phase 1/Phase 2)
Pain (Phase 4)
Phenylephrine (Phase 4)
Postural Orthostatic Tachycardia Syndrome (Early Phase 1)
Pre-Eclampsia (Phase 4)
Pregnancy (Phase 4)
Premature Birth (Phase 3)
Refractive Errors (Phase 4)
Regional Blood Flow (Phase 2)
Respiratory Tract Infections (Phase 3)
Retinal Diseases (Phase 3)
Retinopathy of Prematurity (Phase 4)
Rhinitis (Phase 3)
Rhinitis, Allergic (Phase 3)
Rhinitis, Allergic, Seasonal (Phase 3)
Rhinitis, Vasomotor (Phase 3)
Rhinorrhea (Phase 3)
Sepsis (Phase 4)
Shock (Phase 4)
Shock, Septic (Phase 4)
Sneezing (Phase 3)
Spinal Diseases (Phase 4)
Stomatitis (Phase 1)
Stress Disorders, Post-Traumatic (Phase 2)
Stroke (Phase 3)
Syncope, Vasovagal (Phase 2)
Tachycardia (Phase 4)
Therapeutic Equivalency (Phase 1)
Thoracic Surgery (Phase 4)
Tuberculosis (Phase 4)
Urinary Incontinence (Phase 2)
Vascular Diseases (Early Phase 1)
Vasoconstriction (Phase 1)
Vasodilation (Early Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
